Andreas Schaaf
Freiburg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Engineering the moss Physcomitrium patens to produce proteins with paucimannosidic glycans.
Journal: Frontiers in plant science
Published: April 03, 2025
Effective long-term treatment with moss-produced factor H by overcoming the antibody response in a mouse model of C3G.
Journal: Frontiers in immunology
Published: November 27, 2024
Moss-derived human complement factor H modulates retinal immune response and attenuates retinal degeneration.
Journal: Journal of neuroinflammation
Published: April 22, 2024
Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity.
Journal: Frontiers in immunology
Published: February 06, 2024
Uptake of moss-derived human recombinant GAA in Gaa -/- mice.
Journal: JIMD reports
Published: December 02, 2020
Moss-Derived Human Recombinant GAA Provides an Optimized Enzyme Uptake in Differentiated Human Muscle Cells of Pompe Disease.
Journal: International journal of molecular sciences
Published: March 09, 2020
Pharmacokinetics, pharmacodynamics, and safety of moss-aGalactosidase A in patients with Fabry disease.
Journal: Journal of inherited metabolic disease
Published: October 15, 2018
Host Cell Proteome of Physcomitrella patens Harbors Proteases and Protease Inhibitors under Bioproduction Conditions.
Journal: Journal of proteome research
Published: September 19, 2018
Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders.
Journal: Journal of the American Society of Nephrology : JASN
Published: July 07, 2015
Mannose receptor-mediated delivery of moss-made α-galactosidase A efficiently corrects enzyme deficiency in Fabry mice.
Journal: Journal of inherited metabolic disease
Published: May 04, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026